Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1007/s00535-016-1263-4
Published Online: 2016-10-04
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ikeda, Kenji
Kudo, Masatoshi
Kawazoe, Seiji
Osaki, Yukio
Ikeda, Masafumi
Okusaka, Takuji
Tamai, Toshiyuki
Suzuki, Takuya
Hisai, Takashi
Hayato, Seiichi
Okita, Kiwamu
Kumada, Hiromitsu
Funding for this research was provided by:
Eisai Inc
License valid from 2016-10-04